Wuhan Institute of Biological Products

NCT06298071

Phase 1, Recruiting, 2023, 36 people, 7 Mar 2024, clinicaltrials.gov

NCT05480436

Collaborator, Phase 4, Status unknown, 2022, 1,200 people, 29 Jul 2022, clinicaltrials.gov

NCT05382871

Collaborator, Phase 3, Status unknown, 2022, 1,804 people, 19 May 2022, clinicaltrials.gov

NCT05104437

Collaborator, Phase 4, Status unknown, 2021, 1,440 people, 3 Nov 2021, clinicaltrials.gov

NCT04091880

Collaborator, Phase 4, Completed, 2019, 1,134 people, 17 Sept 2019, clinicaltrials.gov

NCT02764671

Phase 4, Status unknown, 2015, 5,000 people, 6 May 2016, clinicaltrials.gov

NCT02203357

Collaborator, Phase 4, Completed, 2014, 353 people, 29 Jul 2014, clinicaltrials.gov

NCT02152709

Collaborator, Phase 3, Completed, 2008, 1,537 people, 2 Jun 2014, clinicaltrials.gov

Age-dependent immune landscapes affect influenza vaccine effectiveness and guide precision strategies

Employment, 24 Aug 2026, pubmed.ncbi.nlm.nih.gov